Fund focus: Genesis targets China's tech inflection points
With $850 million in dry powder to deploy from its second US dollar-denominated fund, China’s Genesis Capital is targeting Series C and D rounds for start-ups on the cusp of greatness
Genesis Capital’s sweet spot is defined by timing, as well as by industry and size: the Chinese growth-stage investor wants to back technology-enabled companies after their products are proven but before...
More on Greater China
Latest News
Mubadala to invest $1.2b in India's Jio Platforms
Abu Dhabi sovereign wealth fund Mubadala has agreed to invest INR90.9 billion ($1.2 billion) in Jio Platforms, the holding company for various internet and telecom assets owned by Indian oil-to-retail conglomerate Reliance Industries.
Bessemer leads $20m Series B for India's DocsApp
Bessemer Venture Partners has led an INR1.5 billion ($20 million) Series B round for teleconsultation health platform DocsApp.
Chinese drug developer Everest secures $310m Series C
Everest Medicines, a China-based biopharmaceutical company, has raised $310 million in Series C funding across two tranches.
SK Telecom leads Series C for China cloud services player
Bespin Global, a Seoul and Beijing-based cloud management services provider, has raised RMB530 million ($74.6 million) in a Series C round from SK Telecom and existing investor DY Holdings.